A Key Driver Shaping The Chorionic Gonadotropin Market Report 2025: Rising Infertility Rates Leads Industry Growth

January 21, 2025 05:10 PM AEDT | By EIN Presswire
 A Key Driver Shaping The Chorionic Gonadotropin Market Report 2025: Rising Infertility Rates Leads Industry Growth
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, January 21, 2025 /EINPresswire.com/ -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Is Chorionic Gonadotropin Market Headed Towards Steady Growth?
The chorionic gonadotropin market size has shown notable growth in recent years and this trend is set to continue. Expected to grow from $1,260 million in 2024 to $1,340 million in 2025, this sector boasts a compound annual growth rate CAGR of 4.4%. Enhanced awareness of hCG among healthcare professionals, increased use in combating hormonal imbalance disorders, evolving healthcare facilities, and the growing demand for assisted reproduction contribute to this promising historic period growth.

Get Your Free Sample of The Chorionic Gonadotropin Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19888&type=smp

What is the Forecast for the Chorionic Gonadotropin Market?
Moving forward, the chorionic gonadotropin market size is predicted to maintain steady growth, reaching an impressive $1,710 million in 2029 at a CAGR of 4%. This growth stems from key factors such as increased prevalence of infertility issues, heightened awareness of reproductive health, rising adoption of assisted reproductive technologies, a surge in hypogonadism among the elderly population, and expanding healthcare infrastructure. Furthermore, technological advancements, growth in assisted reproductive technology, increased investments in research and development, and innovations in drug delivery systems represent major industry trends.

Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/chorionic-gonadotropin-global-market-report

Which Are the Key Market Drivers for Chorionic Gonadotropin?
Prevalence of infertility issues is a significant market driver for the chorionic gonadotropin market. Defined as the inability to conceive a child after a year of regular, unprotected sexual intercourse for couples under 35 years of age or after six months for those 35 years and older, infertility is increasingly common due to delayed childbearing and lifestyle factors like obesity and smoking. Chorionic Gonadotropin hCG is a crucial treatment inovulation induction, luteal phase support and sperm count improvement.

The rise of assisted reproductive technologies is also promoting the growth of the chorionic gonadotropin market. Assisted reproductive technologies ART, which include procedures to assist in pregnancy, have increased due to higher infertility rates, medical advancements, delayed childbearing, and ease of access.

Who Are The Key Players In The Chorionic Gonadotropin Market?
Notable companies operating in the chorionic gonadotropin market include Ferring Pharmaceuticals. As prominent industry players, they help drive advancements and improvements across the sector.

What Are The Emerging Trends In The Chorionic Gonadotropin Market?
Innovative solutions, such as saliva-based pregnancy tests, are emerging as a significant trend in the chorionic gonadotropin market. A saliva-based pregnancy test, a non-invasive diagnostic method that analyses a woman's saliva for the presence of hCG, offers improved convenience, accuracy, and accessibility. One example includes the world's first saliva-based pregnancy test by Israel-based biotech company Salignostics.

How Is The Chorionic Gonadotropin Market Segmented?
The chorionic gonadotropin market covered in this report includes several key segments:
1 By Type: Human Chorionic Gonadotropin; Animal Chorionic Gonadotropin
2 By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3 By Therapeutic Application: Male Hypogonadism; Female Infertility Treatment; Oligospermic Treatment; Cryptorchidism Treatment; Chronic Pain; Other Therapeutic Applications
4 By End User: Research Institutions; Pharmaceutical Companies

What Is The Regional Outlook For The Chorionic Gonadotropin Market?
North America emerged as the largest region in the chorionic gonadotropin market for 2024. However, Asia-Pacific is predicted to be the quickest-growing region in the forecast period. The report encompasses diverse regions, including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:
Hormone Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report
Biosimilar Growth Hormones Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report
Biosimilar Hormones Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report


About The Business Research Company
With over 15000+ reports across 27 industries encompassing 60+ geographies, The Business Research Company is your go-to for in-depth, data-rich research and insights. Backed by 1,500,000 datasets, our unique insights from industry leaders provide the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.